Χώρα: Ιρλανδία
Γλώσσα: Αγγλικά
Πηγή: HPRA (Health Products Regulatory Authority)
Amoxicillin (as amoxicillin trihydrate)
Ceva Santé Animale
QJ01CA04
Amoxicillin (as amoxicillin trihydrate)
500 milligram(s)/gram
Oral powder
POM: Prescription Only Medicine as defined in relevant national legislation
Chickens, Other Birds, Pigs
amoxicillin
Antibacterial
Authorised
2016-04-22
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Amoxival 500 mg/g oral powder for pigs and chickens. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each gram contains ACTIVE SUBSTANCE: Amoxicillin....................................................... 500.00 mg (as amoxicillin trihydrate 574.00 mg) EXCIPIENTS: For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Oral powder. White or almost white powder. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Pigs (pigs after weaning) and chickens (broilers). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Pigs (after weaning): Treatment of swine pleuropneumonia due to_ Actinobacillus pleuropneumoniae_ (susceptible to amoxicillin). Broiler chickens: Prevention at the group level, when disease is present, of respiratory infections caused by_ Escherichia coli_ (susceptible to amoxicillin). 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to penicillins or other substances of the ß-lactam group. Do not use in animals with serious kidney malfunction including anuria and oliguria. Do not use in presence of - lactamase producing bacteria. Do not use in lagomorphs and rodents such as rabbits, guinea pigs, hamsters or gerbils. Do not use in ruminants or horses. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _1_ _9_ _/_ _1_ _2_ _/_ _2_ _0_ _1_ _6_ _C_ _R_ _N_ _ _ _7_ _0_ _2_ _5_ _1_ _9_ _9_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e Διαβάστε το πλήρες έγγραφο